✦ LIBER ✦

4 P Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBE-positive chronic hepatitis B: Results of an open, controlled trial

✍ Scribed by F. Jaboli; C. Fabbri; S. Liva; F. Azzaroli; G. Nigro; S. Giovanelli; S. Marchetto; A. Colecchia; D. Festi; P. Bacchi; L. Reggiani; C. mazzeo; E. Roda; G. Mazzella

Book ID: 119631177
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 194 KB
Volume: 34
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(02)90222-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon/long-term lamivudine combinat

Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients

✍ NIKOLAOS L NIKOLAIDIS; OLGA I GIOULEME; KONSTANTINOS A TZIOMALOS; ADAMOS S SAVER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Lamivudine and alpha interferon combinat

Lamivudine and alpha interferon combination therapy in patients with anti-HBE-positive chronic hepatitis B: preliminary results of a randomised study

✍ S. Kaymakoglu; K. Demir; Y. Cakaloglu; Z. Durakoglu; D. Dincer; C. Karaca; H. Um 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Long-term efficacy of interferon alpha-2

Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial

✍ Giuseppe Barbaro; Franco Zechini; Adriano M. Pellicelli; Ruggiero Francavilla; G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 109 KB

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENA

P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL

✍ Guyader, D.; Bellissant, E.; Asselah, T.; Bronowicki, J.P.; Abergel, A.; Lasser, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Long-term efficacy of interferon alpha-2

Long-term efficacy of interferon alpha-2B and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial: Giorgio Barbarini, IRCCS S Matteo Univ of Pavia Italy; Franco Zechini, Adriano Pellicelli, Lazzaro Spallanzani Hosp, Rome Italy; Ruggiero Francavilla, General Hosp, Bisceglie Italy; Gaetano Scotto, Infectious Diseases, Foggia Italy; Donato Bacca, Gastroenterology Div, Casarano Italy; Marcello Bruno, Infectious Diseases, Guadagna Hosp, Palermo Italy; Sergio Babudieri, Univ of Sassari Italy; Filippo Matarazzo, Infectious Diseases, Formia Hosp Italy; Mauro Annese, Gastroenterology Svc, Matera Hosp Italy; Gabriele Di Stefano, Infectious Diseases, Latina Hosp Italy; Giuseppe Barbaro, Univ La Sapienza, Rome Italy

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB